Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Evaluate the Effects of GPI 1485 on Erectile Function Following Bilateral Nerve-Sparing Prostatectomy

ClinicalTrials.gov ID: NCT00090376

Public ClinicalTrials.gov record NCT00090376. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 9:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 2, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 3 Arm, 12-Month Study to Evaluate the Effects of GPI 1485 on Erectile Function in Patients Undergoing Bilateral Nerve-Sparing Radical Retropubic Prostatectomy for Prostatic Carcinoma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

In this phase II study, an investigative (not approved by the FDA) drug called GPI 1485 is being assessed to see if it can help preserve erectile function after prostatectomy.

Study identification

NCT ID
NCT00090376
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eisai Inc.
Industry
Enrollment
240 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
40 Years to 69 Years
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2003 (Type not available)
Primary completion
Not listed
Completion
Not listed
Last update posted
Nov 7, 2008

Started 2003

United States locations

U.S. sites
25
U.S. states
16
U.S. cities
22
Facility City State ZIP Site status
HOPE Research Institute, LLC Phoenix Arizona 85032 —
Center for Urological Research La Mesa California 91942 —
Stanford University Medical Center Stanford California 94305-5118 —
Connecticut Surgical Group Hartford Connecticut 06106 —
Connecticut Urological Research at Grove Hill New Britain Connecticut 06052-1395 —
Tulane University Health Sciences Center New Orleans Louisiana 70112 —
Johns Hopkins Hospital Baltimore Maryland 21287 —
University of Michigan Ann Arbor Michigan 48109-0330 —
Henry Ford Health System, Vattikuti Institute for Urology Detroit Michigan 48202 —
Washington University School of Medicine St Louis Missouri 63110 —
PPS Clinical Research, St. Louis St Louis Missouri 63141 —
Hackensack University Medical Center Hackensack New Jersey 07601 —
NYU Urology Associates New York New York 10016 —
Memorial Sloan-Kettering Cancer Center New York New York 10017 —
Columbia University New York New York 10032 —
Carolinas Health Care System McKay Urology Charlotte North Carolina 28204 —
Duke University Medical Center Durham North Carolina 27710 —
The Cleveland Clinic Foundation Cleveland Ohio 44195 —
Urological Associates of Lancaster, Ltd. Lancaster Pennsylvania 17604-3200 —
Carolina Urologic Research Center Myrtle Beach South Carolina 29572 —
Vanderbilt Medical Center Nashville Tennessee 37232-2765 —
The University of Texas MD Anderson Cancer Center Houston Texas 77030-4009 —
The University of Texas Health Science Center at San Antonio San Antonio Texas 78229-3900 —
Virginia Mason Medical Center Seattle Washington 98101 —
Madigan Army Medical Center Tacoma Washington 98431-1100 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00090376, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 7, 2008 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00090376 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →